Venture In The South

E219 The Atticus Pharma Update

Venture In The South Season 5 Episode 219

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 18:49

S5:E219 David interviews Scott Pancoast, the Executive Chairman at Atticus Pharma, a spinout from Zylo Pharma where Scott is CEO. Atticus has 2 drug candidates from their Immunodermatology Platform and Scott updates listeners on the most recent developments at Atticus as they approach a liquidity event in the next few years. (recorded 2.18.26)

Follow David on X at https://x.com/DGRollingSouth

Connect On LinkedIn with David at https://www.linkedin.com/in/davidgrisell/

Follow Paul on X at https://x.com/PalmettoAngel

Connect On LinkedIn with Paul at

https://www.linkedin.com/in/paulclarkprivateequity/

We invite your feedback and suggestions at www.ventureinthesouth.com or email david@ventureinthesouth.com.